Singh, Ramanjit
Imberg, Henrik
Seyed Ahmadi, Shilan
Hallström, Sara
Jendle, Johan
Tengmark, Bengt-Olov
Folino, Anna
Ekström, Marie
Lind, Marcus
Funding for this research was provided by:
University of Gothenburg
Article History
Received: 23 September 2025
Accepted: 20 January 2026
First Online: 31 March 2026
Declarations
:
: J.J has been a lecturer/member of the scientific advisory board in the following companies: Abbott, AstraZeneca, Eli Lilly, MiniMed, Nordic InfuCare, Novo Nordisk A/S, Sanofi, Tandem and Ypsomed. M.L has been a consultant or received honoraria from Boehringer Ingelheim, Eli Lilly, Nordic InfuCare, Novo Nordisk and Rubin Medical. M.L has received research grants from Eli Lilly and Novo Nordisk, all outside of the submitted work. S.H has lectured for Novo Nordisk. All other authors declare that they have no conflict of interest.